|
||
Original Article |
Correspondence to: Richard A. Flavell, Section of Immunobiology, Yale University School of Medicine, 310 Cedar St., FMB 412, New Haven, CT 06520. Tel:203-737-2216 Fax:203-737-2958 E-mail:richard.flavell{at}yale.edu.
Rac2 is a hematopoietic-specific GTPase acting as a molecular switch to mediate both transcriptional activation and cell morphological changes. We have examined the effect of Rac2 deficiency during T cell activation. In Rac2-/- T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptorspecific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signalregulated kinase (ERK)1/2 and p38, and reduced Ca2+ mobilization. TCR stimulationinduced actin polymerization is also reduced. In addition, anti-CD3 cross-linkinginduced T cell capping is reduced compared with wild-type T cells. These results indicate that Rac2 is important in mediating both transcriptional and cytoskeletal changes during T cell activation. The phenotypic similarity of Rac2-/- to Vav-/- cells implicates Rac2 as a downstream mediator of Vav signaling.
Key Words: T cell activation, Rac2, VAV, MAPK, cytoskeleton
This article has been cited by other articles:
| TABLE OF CONTENTS |
|